|
PRKACA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.216200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.829200E-01 |
| Normal-vs-Stage2 |
3.361900E-02 |
| Normal-vs-Stage3 |
1.332010E-01 |
| Normal-vs-Stage4 |
1.516230E-01 |
| Stage1-vs-Stage2 |
2.459000E-03 |
| Stage1-vs-Stage3 |
8.984500E-03 |
| Stage1-vs-Stage4 |
1.690210E-02 |
| Stage2-vs-Stage3 |
2.958400E-01 |
| Stage2-vs-Stage4 |
4.182800E-01 |
| Stage3-vs-Stage4 |
8.834800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.566000E-01 |
| Normal-vs-AfricanAmerican |
6.168000E-01 |
| Normal-vs-Asian |
6.806600E-01 |
| Caucasian-vs-AfricanAmerican |
8.372200E-01 |
| Caucasian-vs-Asian |
6.178000E-01 |
| AfricanAmerican-vs-Asian |
6.263000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.099900E-02 |
| Normal-vs-Female |
1.950190E-01 |
| Male-vs-Female |
3.589900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.602800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.086600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.178590E-01 |
| Normal-vs-Age(81-100Yrs) |
3.615600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.424200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.041350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.692620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.934280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.083600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.815600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.842000E-03 |
| Normal-vs-Grade 2 |
6.929600E-01 |
| Normal-vs-Grade 3 |
8.301600E-02 |
| Normal-vs-Grade 4 |
5.620200E-01 |
| Grade 1-vs-Grade 2 |
3.493700E-02 |
| Grade 1-vs-Grade 3 |
4.556800E-04 |
| Grade 1-vs-Grade 4 |
1.351780E-02 |
| Grade 2-vs-Grade 3 |
8.296500E-03 |
| Grade 2-vs-Grade 4 |
3.505400E-01 |
| Grade 3-vs-Grade 4 |
3.481000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.313800E-01 |
| Normal-vs-ccB subtype |
6.792800E-01 |
| ccA subtype-vs-ccB subtype |
3.918600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.596400E-01 |
| Normal-vs-N1 |
2.901200E-01 |
| N0-vs-N1 |
2.066200E-01 |
|
|
